Distinct effects of different doses of kaempferol on D-GalN/LPS-induced ALF depend on the autophagy pathway

被引:11
|
作者
Tian, Yuan [1 ]
Ren, Feng [1 ]
Xu, Ling [1 ]
Zhang, Xiangying [1 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Beijing Inst Hepatol, 8 Xitoutiao Rd,Youwai St, Beijing 100069, Peoples R China
基金
中国国家自然科学基金;
关键词
kaempferol; acute liver failure; autophagy; liver inflammation; D-galactosamine; lipopolysaccharide; D-GALACTOSAMINE/LIPOPOLYSACCHARIDE; MOUSE-LIVER; MICE; FAILURE; MODEL; INFLAMMATION; ANTIOBESITY; PREVENTION; INHIBITION; APOPTOSIS;
D O I
10.3892/mmr.2021.12321
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Kaempferol, a flavonoid compound, has various biological functions, such as anti-inflammatory and antitumor activities. Acute liver failure (ALF) is a lethal clinical syndrome that occurs due to severe damage of the liver function. In the present study, the mechanisms underlying the therapeutic effects of kaempferol in ALF were evaluated. An ALF mouse model was established using D-galactosamine (D-GalN; 700 mg/kg)/lipopolysaccharide (LPS; 10 mu g/kg). A total of 2 h before the administration of D-GalN/LPS, mice were pretreated with different doses of kaempferol (2.5, 5, 10, 20 and 40 mg/kg), and 6 h after injection of D-GalN/LPS, mice were euthanized. The survival rate, liver function and levels of inflammatory cytokines were assessed. The results demonstrated that kaempferol pretreatment protected hepatocytes from ALF induced by D-GalN/LPS via regulation of the autophagy pathway, both in vivo and in vitro. Pretreatment with a high dose of kaempferol significantly decreased the survival rates and increased severe liver damage; however, pretreatment with a low dose of kaempferol had the opposite effect. Furthermore, pretreatment with a high dose of kaempferol enhanced the levels of proinflammatory cytokines [TNF-alpha, IL-6, IL-12p40, IL-1 beta, C-X-C motif chemokine ligand (CXCL)-2, CXCL-10] and markers of the MAPK signaling pathway [phosphorylated (p)-JNK, p-ERK, p-p38], whereas pretreatment with a low dose of kaempferol had the opposite effect. Pretreatment with a high dose of kaempferol decreased autophagy, whereas pretreatment with a low dose of kaempferol increased autophagy in vivo and in vitro. It was also shown that pretreatment with 3-methyadenine or autophagy related 7 small interfering RNA, to inhibit autophagy, partially abrogated the hepatoprotective effects of pretreatment with 5 mg/kg kaempferol in the ALF mouse model. These results demonstrate that the effects of different doses of kaempferol on D-GalN/LPS-induced ALF varies based on the dose, and that kaempferol exerted its effects via regulation of the autophagy pathway.
引用
收藏
页数:12
相关论文
共 40 条
  • [31] Taraxasterol extracted from Ixeridium gramineum (Fisch.) Tzvel. Attenuated D-GalN/LPS-induced fulminant hepatitis by modulating the JAK/STAT and TNF signalling pathways
    Wang, Gang
    Yin, Yifan
    Lv, Rui
    Ling, Xiumei
    Cao, Houkang
    Liu, Haiping
    Wu, Jianzhao
    Gao, Ya
    Zhang, Kefeng
    Wang, Yongwang
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 340
  • [32] Hepatocyte-specific deletion of type I interleukin-1 receptor (IL-1RI) attenuates D-GalN/LPS-induced acute liver injury in vivo
    Gehrke, N.
    Hoevelmeyer, N.
    Waisman, A.
    Woerns, M. A.
    Galle, P. R.
    Schattenberg, J. M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S341 - S341
  • [33] Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome
    Liu, Yimei
    Liu, Ninghua
    Liu, Yujing
    He, Hongyu
    Luo, Zhe
    Liu, Wenjun
    Song, Nan
    Ju, Minjie
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (03) : 474 - 485
  • [34] Microbial metabolites indole derivatives sensitize mice to D-GalN/LPS induced-acute liver failure via the Tlr2/NF-κB pathway
    Zhou, Ziyuan
    Wang, Baohong
    Pan, Xiaxia
    Lv, Jiawen
    Lou, Zhuoqi
    Han, Yuqiu
    Yao, Yuanyuan
    Chen, Jun
    Wang, Qiangqiang
    Li, Lanjuan
    FRONTIERS IN MICROBIOLOGY, 2023, 13
  • [35] Anti-inflammation and anti-apoptosis effects of growth arrest-specific protein 6 in acute liver injury induced by LPS/D-GalN in mice
    Wang, Qian
    Zhao, Yang
    Zang, Bin
    ACTA CIRURGICA BRASILEIRA, 2020, 35 (02)
  • [36] Long-term expanded hepatic progenitor cells ameliorate D-GalN/LPS-induced acute liver failure through repolarizing M1 macrophage to M2-Like phenotype via activation of the IL-10/JAK2/STAT3 signaling pathway
    Li, Hongsheng
    Chen, Chen
    Huang, Weijian
    Shi, Lei
    Zhang, Qin
    Zhou, Li
    Huang, Hai
    Zhou, Shen'ao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [37] Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway
    Ai, Gaoxiang
    Wu, Xiaoyan
    Dou, Yaoxing
    Huang, Ronglei
    Zhong, Linjiang
    Liu, Yuhong
    Xian, Yanfang
    Lin, Zhixiu
    Li, Yucui
    Su, Ziren
    Chen, Jiannan
    Qu, Chang
    FOOD AND CHEMICAL TOXICOLOGY, 2022, 166
  • [38] Aralia saponin A isolated from Achyranthes bidentata Bl. ameliorates LPS/D-GalN induced acute liver injury via SPHK1/S1P/S1PR1 pathway in vivo and in vitro
    Zeng, Mengnan
    Feng, Aozi
    Wang, Li
    Li, Kun
    Zhou, Jihong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [39] Isolation of Calenduloside E from Achyranthes bidentata Blume and its effects on LPS/D-GalN-induced acute liver injury in mice by regulating the AMPK-SIRT3 signaling pathway
    Guo, Pengli
    Zeng, Mengnan
    Liu, Meng
    Zhang, Yuhan
    Jia, Jufang
    Zhang, Ziyu
    Liang, Shulei
    Zheng, Xiaoke
    Feng, Weisheng
    PHYTOMEDICINE, 2024, 125
  • [40] Effects and mechanisms of frehmaglutin D and rehmaionoside C improve LPS-induced acute kidney injury through the estrogen receptor-mediated TLR4 pathway in vivo and in vitro
    Liu, Meng
    Guo, Pengli
    Zeng, Mengnan
    Zhang, Yuhan
    Jia, Jufang
    Liu, Yanling
    Chen, Xu
    Kuang, Haixue
    Feng, Weisheng
    Zheng, Xiaoke
    PHYTOMEDICINE, 2024, 123